Navigation Links
Three prominent Cell Press journals named among the 100 most influential journals in past 100 years
Date:4/6/2009

CAMBRIDGE, Mass., USA (April 6, 2009) Cell Press, an imprint of Elsevier, announced today that its flagship journal, Cell, as well as Current Biology and The American Journal of Human Genetics, were voted among the Special Library Association's (SLA) Top 100 Journals in Biology and Medicine of the past century.

The Top 100 list is compiled by the 680-plus members of the SLA's Biomedical and Life Sciences Division (DBIO) on the most influential journals in biology and medicine over the last century. The "Journal of the Century" and the Top Ten journal titles will be announced at the Centennial Conference of the Special Libraries Association on June 16th in Washington, D.C.

"We are honoured to be recognized by the SLA for influence and impact in biology, on behalf of Cell Press' two titles Cell and Current Biology, and on behalf of our publishing partner, the American Society of Human Genetics, for the AJHG," said Lynne Herndon, President and CEO of Cell Press.

Established in 1909 to serve a 'specialized' clientele in business, government, social agencies, and academia, the SLA is now an 11,000 member professional organization of subject specialist librarians, information managers, and publishing industry representatives. Each topical division has contributed a Centennial-themed event throughout the year. In 2008, the BioMedical & Life Sciences Division (DBIO) convened an international panel of nine eminent subject experts to compile a ballot for an electronic poll of SLA members concerning the 100 most influential journals of biology and medicine over the 100 years of SLA's existence.

Cell, the pioneer Cell Press title, published its first issue in 1974, and has become one of the most highly-respected and prominent journals in the field. This journal publishes exciting and significant developments in the biological sciences, including cell biology, neuroscience, immunology, virology and microbiology, cancer, human genetics, and disease. Cell's distinct narrative format allows authors to tell a full and complete story, plus creates a unique opportunity to promote interdisciplinary thinking across fields. (www.cell.com)

Current Biology, launched in February of 1991, and became part of Cell Press in early 2001. This journal delivers high-impact research in all areas of biology, from molecular biology to evolution. Current Biology's broad scope, top-flight research papers, and engaging magazine section set it apart as a distinctive leading journal. (www.cell.com/current-biology)

Established in 1949, the American Journal of Human Genetics, is published monthly by Cell Press. This journal provides a record of research and review relating to heredity in humans and to the application of genetic principles in medicine and public policy, as well as in related areas of molecular and cell biology. (www.cell.com/AJHG)


'/>"/>

Contact: Cathleen Genova
cgenova@cell.com
617-397-2802
Cell Press
Source:Eurekalert

Related biology news :

1. Three-way mating game of North American lizard found in distant European relative
2. Columbia to award 2007 Horwitz Prize to three generations of teacher-student scientists
3. Stevens researchers provide oversight for three-year mariculture program in Egypt and Israel
4. Three Dimensional Visualization of Right Ventricle Provides Important Information for Treatment of Patients with Tetralogy of Fallot, According to a Study in The American Journal of Cardiology
5. Researchers document rapid, dramatic reverse evolution in the threespine stickleback fish
6. Scientists integrate data in three dimensions to study climate effects on young fish
7. Wetlands expert: China should think outside the flooding box with Three Gorges Dam
8. Dwarf crocodiles split into three species
9. Joslin research finds nearly three-quarters of youths with diabetes insufficient in vitamin D
10. Four, three, two, one . . . pterosaurs have lift off
11. Tiny details in three dimensions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2016)...   The Weather Company , an IBM Business (NYSE: ... capability in which consumers will be able to interact with ... via voice or text and receive relevant information about the ... Marketers have long sought an advertising solution that can create ... relevant and valuable; and can scale across millions of interactions ...
(Date:5/16/2016)... May 16, 2016   EyeLock LLC , a ... the opening of an IoT Center of Excellence in ... expand the development of embedded iris biometric applications. ... of convenience and security with unmatched biometric accuracy, making ... aside from DNA. EyeLock,s platform uses video technology to ...
(Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... June 27, 2016  Global demand for enzymes ... through 2020 to $7.2 billion.  This market includes ... cleaning products, biofuel production, animal feed, and other ... and biocatalysts). Food and beverages will remain the ... increasing consumption of products containing enzymes in developing ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... medical technologies, services and solutions to the healthcare market. The company's primary focus ... distribution, manufacturing, sales and marketing strategies that are necessary to help companies efficiently ...
(Date:6/24/2016)... DIEGO , June 24, 2016 ... more sensitively detects cancers susceptible to PARP inhibitors ... circulating tumor cells (CTCs). The new test has ... HRD-targeted therapeutics in multiple cancer types. ... targeting DNA damage response pathways, including PARP, ATM, ...
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
Breaking Biology Technology: